A Deep Dive on Genetic Modalities for Rare Disease: Genetic Medicines Are Here

Moderators

Tazeen Ahmad

SMid-Cap Biotech Analyst, BofA Global Research

Patricia Musolino, MD, PhD

Co-Director, Pediatric Stroke and Cerebrovascular Service, Massachusetts General Hospital;

Associate Professor of Neurology, Harvard Medical School

Panelists

Faraz Ali

CEO, Tenaya Therapeutics

Lucas Harrington, PhD

Co-Founder & CSO, Mammoth Biosciences

Raju Prasad, PhD

Chief Financial Officer, CRISPR Therapeutics

Sandi See Tai, MD

Chief Development Officer, Lexeo Therapeutics